ARS Pharmaceuticals, Inc. Other Nonoperating Expense
ARS Pharmaceuticals, Inc. (SPRY) reported Other Nonoperating Expense of $2.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2026-08-13
- ARS Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2026-06-30 was $2.48M.
- ARS Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2026-03-31 was $2.44M.
- ARS Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2025-06-30 was $0.00.
- ARS Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2025-03-31 was $0.00.
- ARS Pharmaceuticals, Inc. other nonoperating expense for fiscal 2025 was $2.60M.
- ARS Pharmaceuticals, Inc. other nonoperating expense for fiscal 2024 was $0.00.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 12 month |
|---|---|---|---|
| 2026-06-30 | $2.48M 10-Q · filed 2026-08-13 | $4.92M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.44M 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | $2.60M 10-K · filed 2026-03-09 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |